Hear Dr. Alan Menter, Chief of Dermatology at Baylor, Scott and White Health in Dallas, TX and Co-Chair of the Guidelines Development Committee, discuss the eleven biologic agents used for the treatment of moderate-to-severe psoriasis and psoriatic arthritis. To view disclosure information and claim credit go to https://www.eeds.com/em/1121 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics. To access guidelines: www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis .

Dr. Mark Lebwohl, the Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai Health System in New York, discusses the latest treatment options used for rapid relief of psoriasis flares (which includes his research around response times to examples of use with patients). To view disclosure information and claim credit, go to https://www.eeds.com/em/1133 . The program is supported by unrestricted educational grants from Lilly and UCB.

Hear a discussion about the systemic nature of psoriasis and how the risk of concurrent health conditions should influence the management and treatment of psoriasis from Dr. So Yeon Paek, dermatologist with Texas Dermatology Associates and Assistant Clinical Professor of Dermatology at Texas A&M Medical School in Dallas. To view disclosure information and claim credit, go to https://www.eeds.com/em/1120 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics. To access the psoriasis guidelines: www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis .

Hear a fascinating insight into the field of glycomics - from glycan function to the relationship to immune mediated diseases such as psoriasis from Dr. Emanual Maverakis, a dermatologist and physician investigator with the Departments of Dermatology, Medical Microbiology and Immunology at University of California, Davis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1119 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.

Hear dermatologist Dr. Abby Van Voorhees, Chair of NPF's Medical Board and Chair of Dermatology at Eastern Virginia Medical School in Norfolk, VA, discuss the symptoms of psoriasis in the ear, potential impact and treatment options. To view disclosure information and claim credit, go to https://www.eeds.com/em/1118 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.

Hear rheumatologist Dr. Arthur Mandelin from Northwestern University, Feinberg School of Medicine in Chicago, compare key features and symptoms of psoriatic arthritis to rheumatoid arthritis, osteoarthritis and gout. Includes a discussion about PsA screening tools. To view disclosure information and claim credit, go to https://www.eeds.com/em/1117 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.

Hear Dr. Joel Gelfand, Director of the Psoriasis and Phototherapy Treatment Center at University of Pennsylvania, expand on his discussion of the value of phototherapy and the patient/provider requirements for becoming involved in the Light Treatment Effectiveness or LITE Study. To view disclosure information and claim credit, go to https://www.eeds.com/em/1114 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.

Dr. Nehal Mehta, a nuclear cardiologist who is Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, MD, talks about his research in understanding the role of innate immunity and inflammation in psoriatic disease, and how it relates to cardiovascular and metabolic diseases. To view disclosure information and claim credit, go to https://www.eeds.com/em/1113 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. To access other CME activities visit https://cme.psoriasis.org .

Hear what the new treatment guidelines for psoriatic arthritis from the American College of Rheumatology and the National Psoriasis Foundation may mean for management of the disease. Dr. Philip Mease, a rheumatologist and Director of the Rheumatology Clinical Research Division at Swedish Medical Center/Providence St. Joseph Health in Seattle, WA, discusses the high points of the guidelines. To view disclosure information and claim credit, go to https://www.eeds.com/em/1112 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. For additional CME education opportunities visit https://cme.psoriasis.org

Hear Dr. Amy Paller, M.D., world renowned pediatric dermatologist at Northwestern University, Feinberg School of Medicine and Director of the Northwestern University Skin Disease Research Center address the use of biologics in youth along with her research in Liproproteins and targeted topical delivery system using gene suppression and nanotherapy. To view disclosure information and claim credit, go to https://www.eeds.com/em/1110 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. For other CME education opportunities visit cme.psoriasis.org .